Tumor cells with MYC overexpression show dysregulation of the cell cycle, which could make their proliferation especially sensitive to the inhibition of cyclin-dependent kinase (CDK), a key regulator of cell cycle progression. This evidence concerns the gene MYC and neoplasm.